EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

No signs of mast cell involvement in long‐COVID: A case–control study

Ole Bernt Lenning iD, Grete Jonsson, Tore Grimstad, Emiel A M Janssen, Geir Sverre Braut iD, Frode Berven, Roald Omdal iD

Scandinavian Journal of Immunology · 2024

DOI: 10.1111/sji.13407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2024. Verfasst von Ole Bernt Lenning und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, Stavanger University Hospital, Stavanger, Norway. Hauptthemen laut MEDLINE: Mast Cells, COVID-19, Tryptases, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EkstraStiftelsen Helse og Rehabilitering (Stiftelsen Dam), Norwegian Brain Council, Stiftelsen Dam.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long‐COVID caused by SARS‐CoV‐2 infection has significant and increasing effects on human health worldwide. Although a unifying molecular or biological explanation is lacking, several pathophysiological mechanisms have been proposed. Involvement of mast cells—evolutionary old “multipurpose” innate immune cells—was reported recently in studies of acute infection and post‐acute‐COVID‐19 syndrome. Mast cell activity has been suggested in long‐COVID. In this case–control study, we compared data from 24 individuals with long‐COVID (according to the NICE criteria) and 24 age‐ and sex‐matched healthy individuals with a history of SARS‐CoV‐2 infection without developing sequelae. Serum levels of the proteases beta‐tryptase (TPSB2) and carboxypeptidase (CPA3), which are mast cell specific, were measured using immunoassays. The values were compared between the two groups and correlated to measures of physical exertional intolerance. TPSB2 and CPA3 levels were median (range) 26.9 (2.0–1000) and 5.8 (1.5–14.0) ng/mL, respectively, in the long‐COVID group. The corresponding values in the control group were 10.9 (2.0–1000) ( p = 0.93) and 5.3 (3.5–12.9) ng/mL ( p = 0.82). No significant correlations between TPSB2 or CPA3 levels and scores on the ten physical subscales of SF‐36, 3.1–3.10 were revealed. We found no significant differences in the levels of mast cell activation markers TPSB2 and CPA3 between the long‐COVID and control groups and no correlations with proxy markers of exercise intolerance. Mast cell activation does not appear to be part of long‐term pathogenesis of long‐COVID, at least in the majority of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsCOVID-19TryptasesSARS-CoV-2Carboxypeptidases AHumansMaleCase-Control StudiesFemaleMiddle AgedAdultAgedPost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

exertional intolerancelong‐COVIDmast cellsmast cell‐derived proteases

Substanzen

TryptasesCarboxypeptidases ACPA3 protein, humanTPSAB1 protein, human

Autor:innen und Institutionen

  • Research Department, Stavanger University Hospital, Stavanger, Norway.
  • Department of Medical Biochemistry, Stavanger University Hospital, Stavanger, Norway.
  • Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Pathology, Stavanger University Hospital, Stavanger, Norway.
  • Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.

ORCID-Profile: Ole Bernt Lenning, Geir Sverre Braut, Roald Omdal

Förderung

  • EkstraStiftelsen Helse og Rehabilitering (Stiftelsen Dam)
  • Norwegian Brain Council
  • Stiftelsen Dam

Zitieren

APA

Lenning, O. B., Jonsson, G., Grimstad, T., Janssen, E. A. M., Braut, G. S., Berven, F., & Omdal, R. (2024). No signs of mast cell involvement in long‐COVID: A case–control study. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13407

Vancouver

Lenning OB, Jonsson G, Grimstad T, Janssen EAM, Braut GS, Berven F, et al. No signs of mast cell involvement in long‐COVID: A case–control study. Scandinavian Journal of Immunology. 2024. doi:10.1111/sji.13407

BibTeX
@article{Lenning2024,
  author = {Lenning, Ole Bernt and Jonsson, Grete and Grimstad, Tore and Janssen, Emiel A M and Braut, Geir Sverre and Berven, Frode and Omdal, Roald},
  title = {No signs of mast cell involvement in long‐COVID: A case–control study},
  journal = {Scandinavian Journal of Immunology},
  year = {2024},
  doi = {10.1111/sji.13407}
}
Kostenlos starten →